Xenon Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
22 April 2023 - 6:01AM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused
biopharmaceutical company, today announced that it will host a
company presentation at the 2023 Bloom Burton & Co. Healthcare
Investor Conference to be held in Toronto, Ontario from April
25-26, 2023.
Company Presentation Details: |
|
|
Date: |
Tuesday, April 25, 2023 |
|
|
Time: |
11:00 am Eastern Time (8:00 am Pacific Time) |
|
|
Webcast: |
Register here |
|
|
Presenter: |
Ian Mortimer, President and CEO |
A live webcast of the company presentation will be available on
the “Investors” section of Xenon's website and posted for replay
following the event. The above listed dates and times are subject
to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a
clinical stage biopharmaceutical company committed to developing
innovative therapeutics to improve the lives of patients with
neurological disorders. We are advancing a novel product pipeline
of neurology therapies to address areas of high unmet medical need,
with a focus on epilepsy. For more information, please visit
www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Investor/Media Contact:Jodi RegtsXenon
Pharmaceuticals Inc.Phone: 604.484.3353Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Apr 2023 to Apr 2024